<li>aliskiren<p>simvastatin will increase the level or effect of aliskiren by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>alvimopan<p>simvastatin will increase the level or effect of alvimopan by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>ambrisentan<p>simvastatin will increase the level or effect of ambrisentan by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>armodafinil<p>simvastatin will increase the level or effect of armodafinil by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>coenzyme q10<p>simvastatin decreases levels of coenzyme q10 by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>colestipol<p>colestipol decreases levels of simvastatin by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>fenofibrate<p>fenofibrate increases levels of ezetimibe by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>fenofibrate micronized<p>fenofibrate micronized increases levels of ezetimibe by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>fenofibric acid<p>fenofibric acid increases levels of ezetimibe by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>fexofenadine<p>simvastatin will increase the level or effect of fexofenadine by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>fluvoxamine<p>fluvoxamine will increase the level or effect of simvastatin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>gemfibrozil<p>gemfibrozil increases levels of ezetimibe by enhancing GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>isradipine<p>isradipine decreases levels of simvastatin by unknown mechanism. Minor/Significance Unknown.</p></li>